NextPlat shares surge 10.14% intraday as PharmcoRx secures multi-state prescription fulfillment contract with DevotedDOc.

NextPlat surged 10.14% intraday trading following the announcement that its PharmcoRx subsidiary secured an exclusive multi-state prescription fulfillment contract with virtual medical group DevotedDOc. The agreement, effective in November 2025, will see PharmcoRx fulfill prescriptions for patients in Florida and Georgia, with potential national expansion supported by its non-resident pharmacy licenses in 11 additional states. The contract aligns with NextPlat’s healthcare division’s strategy to expand its revenue channels and geographic footprint, leveraging its existing infrastructure and licensing. The deal, which supports medication fulfillment for opioid addiction, weight loss, and hormone replacement therapies, underscores the company’s growth in healthcare services and positions it to capitalize on recurring operational relationships. The news, reiterated across multiple reports, directly correlates with the intraday rally, reflecting investor optimism about the new partnership and its scalability.